Nevro Corp (NYSE:NVRO)
$ 4.58 0.26 (6.02%) Market Cap: 171.62 Mil Enterprise Value: 141.17 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 43/100

Nevro Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 04:15PM GMT
Release Date Price: $18.72 (-7.83%)
Allen Gong JPMorgan;Analyst

Morning, everyone. Welcome to the final day of the JPMorgan Healthcare Conference. My name is Allen Gong on the medical supplies and devices team really excited to be introducing the management team of never today.

We're going to start off with prepared remarks from CEO, Kevin Varin, all before moving to an open Q&A with the broader management team from the sorry, appreciate it.

Kevin Thornal
Nevro Corp - President, Chief Executive Officer, Director

Thanks, everybody, for your interest in the Company.

Obviously, the first page forward looking statements, please make it a chance to look over those.

And we may talk about non-GAAP financial measures which you can read on this slide as well.

So whenever we have a unique value proposition, we have multiple growth drivers in a very large and diversified spinal cord stimulation market and we have new indications, not only that we have today, but also new indications coming for use of neuromodulation in the spinal cord for different disease

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot